Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Issued
Ratios

Bioventus (BVS) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • Bioventus' Accumulated Depreciation & Amortization fell 3230.02% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3230.02%. This contributed to the annual value of $7.7 million for FY2024, which is 1345.85% down from last year.
  • As of Q3 2025, Bioventus' Accumulated Depreciation & Amortization stood at $1.4 million, which was down 3230.02% from $1.4 million recorded in Q2 2025.
  • Bioventus' 5-year Accumulated Depreciation & Amortization high stood at $34.9 million for Q4 2021, and its period low was $1.4 million during Q3 2025.
  • Its 5-year average for Accumulated Depreciation & Amortization is $5.0 million, with a median of $2.2 million in 2022.
  • Over the last 5 years, Bioventus' Accumulated Depreciation & Amortization had its largest YoY gain of 4557.24% in 2022, and its largest YoY loss of 7204.87% in 2022.
  • Quarter analysis of 5 years shows Bioventus' Accumulated Depreciation & Amortization stood at $34.9 million in 2021, then plummeted by 72.05% to $9.7 million in 2022, then decreased by 9.29% to $8.8 million in 2023, then decreased by 13.46% to $7.7 million in 2024, then plummeted by 81.73% to $1.4 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.6 million for Q1 2025.